Cul4 E3 ubiquitin ligase regulates ovarian cancer drug resistance by targeting the antiapoptotic protein BIRC3

CRL4, a well-defined E3 ligase, has been reported to be upregulated and is proposed to be a potential drug target in ovarian cancers. However, the biological functions of CRL4 and the underlying mechanism regulating cancer chemoresistance are still largely elusive. Here, we show that CRL4 is conside...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xiaoyan, Meng, Yang, Xu, Lian, Qiu, Lei, Wei, Mingtian, Su, Dan, Qi, Xu, Wang, Ziqiang, Yang, Shengyong, Liu, Cong, Han, Junhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362125/
https://www.ncbi.nlm.nih.gov/pubmed/30718461
http://dx.doi.org/10.1038/s41419-018-1200-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362125/
https://www.ncbi.nlm.nih.gov/pubmed/30718461
http://dx.doi.org/10.1038/s41419-018-1200-y

Ejemplares similares